---
figid: PMC10341681__ijms-24-10505-g002
figtitle: Signaling pathways and targets of AB metabolism regulation by saponins
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10341681
filename: PMC10341681__ijms-24-10505-g002.jpg
figlink: /pmc/articles/PMC10341681/figure/F2
number: F2
caption: The signaling pathways and targets of Aβ metabolism regulation by saponins.
  (1). Ginsenoside Rg1 and xanthoperidinol, to inhibit Aβ formation by reducing APP
  production; (2). Ginsenoside Rg1 and theasaponin E1, can enhance α-secretase activity
  and decrease β-secretase and γ-secretase activity; (3). Ginsenoside Rg1, regulates
  targets of PKC, MAPK, and PI3Ksignaling pathways; (4). RAPO-1-3, onjisaponin B,
  and PF11, can decrease β-secretase activity; (5). CK, can reduce the expression
  of BACE1 and PS1 and increase the activity of IDE; (6). Ginsenoside Rg1, regulates
  targets of PKA/pCREB signaling pathways; (7). Minor ginsenoside F1, can enhance
  the expression of pCREB; (8). PF11, can recover Rab conversions; (9). Ginsenoside
  Re, NTR1, AS-IV, Jujuboside A, and ginsenoside Rg1, regulate targets of PPARγ signaling
  pathways; (10). Hederacolchiside-E, polanoside A, chikusetsu saponin V, NTR1, and
  Akquintoside F, can directly inhibit the neurotoxicity of Aβ. The above-mentioned
  saponins inhibit the metabolism of Aβ by modulating the targets of these signaling
  pathways
papertitle: 'Therapeutic Candidates for Alzheimer’s Disease: Saponins'
reftext: Ruifeng Zhang, et al. Int J Mol Sci. 2023 Jul;24(13).
year: '2023'
doi: 10.3390/ijms241310505
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Alzheimer’s disease | saponin | amyloid beta | inflammation | oxidative
  stress | apoptosis
automl_pathway: 0.9306815
figid_alias: PMC10341681__F2
figtype: Figure
redirect_from: /figures/PMC10341681__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10341681__ijms-24-10505-g002.html
  '@type': Dataset
  description: The signaling pathways and targets of Aβ metabolism regulation by saponins.
    (1). Ginsenoside Rg1 and xanthoperidinol, to inhibit Aβ formation by reducing
    APP production; (2). Ginsenoside Rg1 and theasaponin E1, can enhance α-secretase
    activity and decrease β-secretase and γ-secretase activity; (3). Ginsenoside Rg1,
    regulates targets of PKC, MAPK, and PI3Ksignaling pathways; (4). RAPO-1-3, onjisaponin
    B, and PF11, can decrease β-secretase activity; (5). CK, can reduce the expression
    of BACE1 and PS1 and increase the activity of IDE; (6). Ginsenoside Rg1, regulates
    targets of PKA/pCREB signaling pathways; (7). Minor ginsenoside F1, can enhance
    the expression of pCREB; (8). PF11, can recover Rab conversions; (9). Ginsenoside
    Re, NTR1, AS-IV, Jujuboside A, and ginsenoside Rg1, regulate targets of PPARγ
    signaling pathways; (10). Hederacolchiside-E, polanoside A, chikusetsu saponin
    V, NTR1, and Akquintoside F, can directly inhibit the neurotoxicity of Aβ. The
    above-mentioned saponins inhibit the metabolism of Aβ by modulating the targets
    of these signaling pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR1
  - ERAL1
  - APP
  - AXL
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ADAM10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - RAB5A
  - RAB7A
  - RAB7B
  - TFEB
  - IDE
  - ERa
  - APP
  - CAMP
  - IDE
---
